Prevention of allergy and asthma

Clinical and Experimental Allergy Reviews

Volumn 3, Issue 1, 2003, Pages 51-57

  Baena Cagnani, C E ^a,c   Serra, H ^b   Teijeiro, A ^a   Croce, J S ^a  

^a Hospital Infantil Municipal de Cordoba   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c NONE   (Argentina)

Author keywords

Asthma; Atopy; Environment; Genetics; Immunology; Prevention

Indexed keywords

ALLERGEN; CYTOKINE; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

AFRICA; ALLERGIC RHINITIS; ALLERGY; ASIA; ASTHMA; ATOPIC DERMATITIS; ATOPY; CENTRAL AMERICA; CONFERENCE PAPER; CORRELATION ANALYSIS; DIET; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG COST; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIC; HUMAN; INFECTION RISK; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SOCIOECONOMICS; SOUTH AMERICA; SYMPTOMATOLOGY; WESTERN EUROPE;

EID: 0037326981     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2003.00052.x     Document Type: Conference Paper

References (69)

1. ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet 1998; 351:1225-32.
2. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-60.
3. Shirakawa T, Enamoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77-9.
4. Paunio M, Heibonen OP, Virtanen M et al. Measles history and atopic diseases: a population-based cross-sectional study. JAMA 2000; 283:343-6.
5. Gereda JE, Leung DY, Thatayatikom A. Relation between housedust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 2000; 355:1680-3.
6. Park J, Gold DR, Spiegelman DL et al. House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 2001; 163:322-8.
7. Sung RY, Hui SH, Wong CK et al. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr 2001; 160:117-22.
8. Bont L, Heijnen C, Kavelaars A et al. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001; 184:355-8.
9. 2 muscarinic receptor dysfunction, and antiviral effects. J Exp Med 1999; 190:1465-78.
10. Hakonarson H, Carter C, Maskeri N et al. Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1 beta. Am J Physiol 1999; 277:L12-21.
11. Walter MJ, Kajiwara N, Karanja P et al. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001; 193:339-51.
12. Bjorksten B, Naaber P, Seep E et al. The intestinal microflora in allergic Estonian and Swedish 2-year old children. Clin Exp Allergy 1999; 29:342-6.
13. Matricardi PM, Bonini S. High microbial turnover rate preventing atopy: a evolution to inconsistencies imprinting on the Hygiene hypothesis. Clin Exp Allergy 2000; 30:1506-10.
14. Herz U, Lacy P, Renz H, Erb K. The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol 2000; 12:632-40.
15. Ristori G, Buttinelli C, Pozzili C et al. Microbe exposure, innate immunity and autoimmunity. Immunol Today 1999; 20:54.
16. Mao XQ. The link between helmintic infection and atopy. Parasitol Today 2000; 16:186-8.
17. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type-I diabetes. The analysis of the data in published trends. Diabetologia 1999; 42:1395-403.
18. Cherubini V, Carle F, Ianilli A et al. Large incidence variation of type-I diabetes in Central-Southern Italy 1990-95: lower risk in rural areas. Diabetologia 1999; 42:789-92.
19. Matsuzaki T, Nagata Y, Kado I et al. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 1997; 105:643-9.
20. Oddy WH, Holt PG, Sly PD et al. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. Br Med J 1999; 319:815-9.
21. Muntoni S, Cocco P, Aru G, Cucca F. Nutritional factors worldwide incidence of childhood type 1 diabetes. Am J Clin Nutr 2000; 71:1525-9.
22. Sakaguchi S. Regulatory T cell: key controllers of immunologic self-tolerance. Cell 2000; 101:455-8.
23. Mahanty S, Nutran TB. Immunoregulation in human lymphatic filariasis the role of interleukin 10. Parasite Immunol 1995; 17:385-92.
24. Doetze A, Sataguina J, Burchard G et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th 3/Tr 1-type cytokines IL-10 and transforming growth factor-beta but not by a Th 1 to Th 2 shift. Int Immunol 2000; 12:623-30.
25. Van den Biggelaar AH, van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723-7.
26. Akdis CA, Akdis M, Trautmann A, Blazer K. Immune regulation in atopic dermatitis. Curr Opin Immunol 2000; 12:641-6.
27. Nakao A. Is TGF-beta 1 the key to suppression of human asthma? Trends Immunol 2001; 22:115-8.
28. Casolaro V, Georas SN, Song Z, Ono SJ. Biology and genetics of atopic diseases. Curr Opin Immunol 1996; 8:796-803.
29. Rackemann FM. The evolution of allergy. Univ Mich Med Cent J 1968; 34:3-4.
30. Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:528-33.
31. Marsh DG, Hsu SH, Roebber M et al. HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Medical 1982, 155:1439-51.
32. Cookson WO, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989; 1:1292-5.
33. Cookson Wo, Young RP, Sandford AJ et al. Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1992; 340:381-4.
34. Szepetowski P, Gaudray P. FCER1B, a candidate gene for atopy, is located in 11q13 between CD20 and TCN1. Genomics 1994; 19:399-400.
35. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264:1152-6.
36. Meyers DA, Postma DS, Panhuysen CI et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994; 23:464-70.
37. Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 and its correlation with atopy. Int J Mol Med 1999; 3:3-10.
38. Symula DJ, Frazer KA, Ueda Y et al. Functional screening of an asthma QTL in YAC transgenic mice. Nat Genet 1999; 23:241-4.
39. de Waal Malefyt R, Abrams JS, Zurawski SM et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 1995; 7:1405-16.
40. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
41. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282:2261-3.
42. Ober C, Cox NJ, Abney M et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998; 7:1393-8.
43. Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105:506-13.
44. Deichmann KA, Heinzmann A, Forster J et al. Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. Clin Exp Allergy 1998; 28:151 5.
45. Kruse S, Japha T, Tedner M et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96:365-7146.
46. Mitsuyasu H, Isaura K, Mao XO et al. Ile50V al variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat General 1998, 19:119-2047.
47. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998: 102:165-9.
48. Heinzmann A, Mao XQ, Akaiwa M et al. Genetics variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9:549-59.
49. Gao PS, Mao XQ, Roberts MH et al. Variants of STAT6 (signal transducer and activator of transcription 6) in atopic asthma. J Med Genet 2000; 37:380 2.
50. Baldini M, Lohman IC, Halonen M et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum. Am J Respir Cell Mol Biol 1999; 20:976-83.
51. Szalai C, Kozma GT, Nagy A et al. Polymorphism in the gene regulatory region of MXP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108:375-81.
52. Marks GB, Bauman A for NSW Health Department Asthma Data Working Group. Use of preventer medications and written asthma management plans among adults with asthma in New South Wales. Med J Aust 2000; 16:407-10.
53. Peat JK. Prevention of asthma. Eur Respir J 1996; 9:1545-55.
54. Peat JK. Can Asthma been prevented? Evidence from epidemiological studies of children in Australia and New Zealand in the last decade. Clin Exp Allergy 1998; 28:261-5.
55. Becker AB. Is Primary Prevention of Asthma Possible? Pediatric Pulmonol 2000; 30:63-72.
56. Sly PD, Holt PG. Primary prevention of asthma in infants: fact or fiction. Clin Asth Rev 1997; 1:13-7.
57. Host A, Boner A, Custovic A. Preventive Measures. Allergy 2000, 55:1080-3.
58. Warner JO. Prediction and prevention of asthma. Textbook of Pediatric Asthma: An International Perspective. London: Martin Dunitz, 2001. Chap 19, 359-76.
59. Kalliomaki M. Salmiren S, Isoluri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001: 1357.
60. Helms P, Christie G. Prospects for preventing asthma. Arch Dis Child 1999; 80:401-5.
61. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic disorders in infancy. J Allergy Immunol 1992; 90:235-41.
62. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of 2 years. Clin Exp Allergy 1993; 23:504-11.
63. Woodcock A, Custovic A. Allergen avoidance: does it work? Br Med Bull 2000; 56:1071-86.
64. Licccardi G, D'Amato G. Pets and cockroaches: two increased causes of respiratory allergy in indoor environments. Characteristics of airways sensitization and prevention strategies. Respir Med 2000; 94:1109-18.
65. Htut T, Gill GW, Syed N. Eradication of house dust mite from homes of atopic asthmatic subjects: a double-blind trial. J Allergy Clin Immunol 2001; 107:55-60.
66. Matricardi PM, Rosmini F, D'Amelio R. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997; 314:987-8.
67. Kramarz P, Destefano F. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138:301-3.
68. Nahori MA, Lefort J. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyper-responsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine 2001; 19:1484-95.
69. Gern JE, Busse WW. The role of viral infections in the natural history of asthma. JACI 2000; 106:201-12.